Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.

Cormorbity means the co-occurrence of one or more diseases or disorders in an individual. The National Comorbity Project aims to highlight this type of comorbity and identify appropriate strategies and policies responses.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

This publication presents evidence about the magnitude and severe consequences of comorbidity of mental and physical illnesses from a personal and societal perspective. Leading experts address the huge burden of co-morbidity to the affected individual as well as the public health aspects, the costs to society and interaction with factors stemming from the context of socioeconomic developments. The authors discuss the clinical challenge of managing cardiovascular illnesses, cancer, infectious diseases and other physical illness when they occur with a range of mental and behavioral disorders, including substance abuse, eating disorders and anxiety. Also covered are the organization of health services, the training of different categories of health personnel and the multidisciplinary engagement necessary to prevent and manage comorbidity effectively. The book is essential reading for general practitioners, internists, public health specialists, psychiatrists, cardiologists, oncologists, medical educationalists and other health care professionals.

This book reviews the myriad of elements that layer substance abuse disorder, a significant public health issue. It addresses the strong stigma associated with the disease, particularly in regard to the doctor patient relationships. The book begins by explaining the importance of integrating psychiatric and substance use disorder treatment by demonstrating the efficacy of this treatment model. Subsequent to this are chapters dedicated to specific addiction disorders, including cocaine, opioids, gambling, food, and sex addictions. Chapters also examine how addiction can differ among various neurobiological, genetic, socioeconomic, and age demographics. The book closes with histories, policies, and modalities of drug use which serve as a key component to building a foundation for effective and ethical health policy. Written by international experts in addiction psychiatry, Substance and Non-Substance Related Addictions: A Global Approach is a valuable resource for all practitioners seeking to expand their knowledge of addiction medicine.

Learn more effective treatments for adolescents with abuse substance disorder Dual diagnosis of adolescent substance use disorders and comorbid psychiatric disorders must be treated simultaneously to be effective. Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors presents leading experts offering insightful viewpoints and dynamic suggestions on how to best provide simultaneous treatment and integrated services to these youths. The book covers the state of the art in the field of substance use disorders, and reviews different psychiatric disorders and high risk behaviors, and then addresses the issue of integrated services and ethical, legal, and policy issues pertaining to this population. In the field of adolescent substance abuse treatment, dual diagnosis is the rule rather than the exception, making assessment and treatment complicated. Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors comprehensively discusses the magnitude, etiology, and characteristics of problems and substance abuse disorders (SUD), and extensively explains ways to assess, treat, and develop services for adolescents. This unique text closely examines the assessment and treatment of psychiatric comorbid disorders among adolescents such as depression, anxiety disorders, ADHD, and high risk behaviors including suicidal behavior, self-harm behavior, and gambling behavior. The text is extensively referenced and several chapters include helpful tables and figures to clearly display the data. Topics examined in Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors include: etiology of adolescent substance abuse assessment treatment planning psychosocial interventions pharmacological interventions disruptive behavior disorders attention deficit hyperactivity disorder depression bi-polar mood disorder anxiety disorders trauma and post traumatic stress disorder (PTSD) suicidal and self-harm behaviors schizophrenia eating disorder gambling behavior Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors is an invaluable resource for mental health professionals, pediatricians, family physicians, nurses, addictions specialists, counselors, educators, students, and drug court professionals who provide assessment and treatment for youths with substance use disorders.

Each year, more than 33 million Americans receive health care for mental or substance-use conditions, or both. Together, mental and substance-use illnesses are the leading cause of death and disability for women, the highest for men ages 15-44, and the second highest for all men. Effective treatments exist, but services are frequently fragmented and, as with general health care, there are barriers that prevent many from receiving these treatments as designed or at all. The consequences of this are seriousâ€"for these individuals and their families; their employers and the workforce; for the nation's economy; as well as the education, welfare, and justice systems. Improving the Quality of Health Care for Mental and Substance-Use Conditions examines the distinctive characteristics of health care for mental and substance-use conditions, including payment, benefit coverage, and regulatory issues, as well as health care organization and delivery issues. This new volume in the Quality Chasm series puts forth an agenda for improving the quality of this care based on this analysis. Patients and their families, primary health care providers, specialty mental health and substance-use treatment providers, health care organizations, health plans, purchasers of group health care, and all involved in health care for mental and substanceâ€"use conditions will benefit from this guide to achieving better care.

Trauma and Substance Abuse explores the underrecognized connection between trauma, substance use, and posttraumatic stress disorder (PTSD). Patients with trauma related distress such as PTSD often have comorbid substance use disorders (SUDs). This book presents cutting-edge research on how often the two disorders co-occur and why. Authors describe models of comorbidity and explore how specific PTSD and substance use symptoms are functionally related to each other. In addition, they suggest assessment approaches and practice guidelines to facilitate proper diagnosis and treatment. Particularly valuable are descriptions of several new treatment approaches that have been developed specifically for PTSD-SUD, including cognitive-behavioral and exposure therapy. This is the first book to evaluate and synthesize the two fields of PTSD and substance use disorder research and treatment. This volume is indispensable for researchers and clinicians seeking a full understanding of the etiology, assessment, and treatment of this challenging dual diagnosis.

This book is a guide for psychologists working with substance users in different healthcare settings, from private clinical practice to larger health institutions and community services. It presents a comprehensive overview of the different aspects involved with substance use disorders from a psychological perspective, from prevention to recovery. The volume offers an integrative view about neurobiological, behavioral and psychosocial aspects related to becoming a substance user; shows how psychological assessment tools can be used to diagnose substance use disorders; describes how different kinds of psychotherapy can be applied in the treatment of substance use disorders; and presents a range of evidence-based clinical and social interventions designed for both prevention and treatment of substance use disorders. Apart from covering the whole range of services related to the prevention, diagnosis and treatment of substance use disorders, the volume also shows how these issues can be approached from different theoretical perspectives within psychology, such as: Behavioral and Cognitive Psychology Neuropsychology Existential Psychology Phenomenology Psychoanalysis Analytical Psychology Community and Social Psychology Psychology of Substance Abuse: Psychotherapy, Clinical Management and Social Intervention will be a useful resource for psychologists and other health professionals working with substance users, as well as to undergraduate and graduate students looking for a comprehensive introduction to the psychology of substance abuse.

Substance use and substance use disorders (SUDs) have been documented in a number of cultures since the beginnings of recorded time and represent major societal concerns in the present day. The Oxford Handbook of Substance Use and Substance Use Disorders provides comprehensive reviews of key areas of inquiry into the fundamental nature of substance use and SUDs, their features, causes, consequences, course, treatment, and prevention. It is clear that understanding these various aspects of substance use and SUDs requires a multidisciplinary perspective that considers the pharmacology of drugs of abuse, genetic variation in these acute and chronic effects, and psychological processes in the context of the interpersonal and cultural contexts. Comprising two volumes, this Handbook also highlights a range of opportunities and challenges facing those interested in the basic understanding of the nature of these phenomena and novel approaches to assess, prevent, and treat these conditions with the goal of reducing the enormous burden these problems place on our global society. Chapters in Volume 1 cover the historical and cultural contexts of substance use and its consequences, its epidemiology and course, etiological processes from the perspective of neuropharmacology, genetics, personality, development, motivation, and the interpersonal and larger social environment. Chapters in Volume 2 cover major health and social consequences of substance involvement, psychiatric comorbidity, assessment, and interventions. Each chapter highlights key issues in the respective topic area and raises unanswered questions for future research. All chapters are authored by leading scholars in each topic. The level of coverage is sufficiently deep to be of value to both trainees and established scientists and clinicians interested in an evidenced-based approach.